Illinois Injury and Mass Tort Lawyer Blog

Published on: April 22, 2025

Monsanto Hit With $2B Verdict After Jury Finds Roundup Weed Killer Caused GA Man’s Cancer

lawn-mower-384589_640-e1744669896483 Recently, after a three-week trial, jurors in a state court awarded $2 billion in punitive damages to a plaintiff who had sued Bayer-owned Monsanto and alleged that the company’s Roundup herbicide had caused his cancer. Around $65 million in compensatory damages was awarded for non-Hodgkin lymphoma that the plaintiff argued he developed after using the weed killer. This is one of the largest verdicts in a Roundup case—Bayer plans to appeal. If you developed cancer because you were exposed to Roundup, you should call the seasoned product liability lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved around the nation.

Consult Moll Law Group About Your Claim

The plaintiff had used the herbicide in his own yard. Doctors diagnosed him with non-Hodgkin lymphoma in 2020. His case was brought with allegations that the active ingredient in the weedkiller was glyphosate, which caused his cancer. He argued that Monsanto failed to warn him that the product was dangerous. His case is one of more than 60,000 similar cases. Bayer has paid around $10 billion to settle claims that the herbicide causes cancer and has set aside $5.9 billion to address legal proceedings.

Bayer had acquired Roundup when it took over the agrochemical company Monsanto in 2018. The German pharmaceutical and biotechnology group acquired Roundup as part of its $63 billion takeover of U.S. agrochemical company Monsanto in 2018. In response to this latest verdict, the company said it disagreed with the verdict, and claimed it was in conflict with an overwhelming amount of scientific evidence to the contrary, as well as the consensus of numerous regulatory bodies around the globe. It plans to appeal. Bayer has also said that it may stop selling Roundup if lawmakers don’t strengthen legal protections against product liability litigation.

Continue reading →

Published on: April 15, 2025

ICU Medical Voluntarily Recalls Lots of Potassium Chloride Injection Bags

By Moll Law Group

intravenous-141551_640-e1741659930879 Recently, ICU Medical, Inc. voluntarily recalled certain lots of potassium chloride injection bags with overwrap labels. This came after a customer complaint was received that Potassium Chloride Inj. Bags that had overlap labels of 20 mEq, which incorrectly identify the bag as Potassium Chloride Inj. 10mEq. This mislabeling has the potential to cause harm. If you were harmed due to improperly labeled potassium chloride, you should call the seasoned Chicago-based lawyers of Moll La Group to determine your legal options. Billions have been recovered in cases with which we’ve been involved around the country.

Contact Moll Law Group About a Potassium Chloride Claim

The manufacturer has recalled certain batches of Potassium Chloride due to the possibility of mislabeling on product overwraps so that certain units are identified as 10 mEq instead of 20 mEq. When that incorrect overwrap is in place, the correct 20 mEq label fixed to the bag can’t be seen easily. This can cause serious problems.

If a health care provider calculates the patient’s dose of the medication using the 10mEq label, the patient will get an intravenous overdose of potassium chloride. This can lead to problems like death from cardiac arrest, dysrhythmias, hypotension, confusion, and neuromuscular dysfunction such as ascending paralysis, vertigo, mental confusion and vertigo. Various groups are at real risk for adverse or even fatal consequences; these groups include premature infants, patients who have had cardiac arrhythmia, patients who have had chronic renal insufficiency or acute renal failure, and patients on chronic parenteral nutrition. However, it should be noted that there haven’t been reports of adverse events due to the mislabeling thus far.

Continue reading →

Published on: April 8, 2025

Millions of Popular Granola Bars Sold Across the U.S. Recalled

By Moll Law Group

According to the Food and Drug Administration (FDA), on December 9, 20240 food-2202344_1280-e1741658256100 4, the Chicago-based company Riverside Natural Foods voluntarily recalled over 2.4 million cases of the popular MadeGood granola bars because of the potential presence of metal in the bars. These bars have been sold across the country. If you were harmed by unsafe food call the seasoned Chicago-based attorneys of Moll Law Group to find out your legal options. Billions have been recovered in cases with which we’ve been involved.

Call the Lawyers of Moll Law Group About Your Granola Bar Claim

The Class II recall applies to several different kinds of MadeGood granola bars, which have been touted as healthier allerge-free and organic snack alternatives. The affected bars were made between January-November 2024 and were distributed across the country and internationally.

Class II recalls are instituted when the recalled products can cause temporary or medically reversible adverse health consequences. The manufacturer claims that the recall has been initiated out of an abundance of caution.

Continue reading →

Published on: April 1, 2025

Listeria Outbreak Affects Frozen Supplement Shakes

By Moll Law Group

chocolate-smoothie-1058191_640-e1741658058922 A multistate outbreak of listeria monocytogenes has impacted frozen supplement shakes made by Prairie Farms. As of February 21, 2025, 38 people have been infected by the outbreak across 21 states. On February 22, 2025, Lyons Magnus LLC recalled affected Prairie Farms supplement shakes and people were advised not to sell, eat or serve them. The Centers for Disease Control (CDC), along with officials have been gathering data to figure out the causes of this outbreak. If you were harmed by supplemental shakes contaminated with listeria monocytogenes, you should call the knowledgeable Chicago-based food safety lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved.

Call Seasoned Moll Law Group About Your Supplement Shake Claim

As of February 21, 2025, 38 people infected with the outbreak strain of Listeria monocytogenes have been reported from 21 states. Sick people’s samples were collected on dates ranging from August 17, 2018, to January 23, 2025. Of 38 people with information available, 37 have been hospitalized. Twelve deaths have been reported from California, Illinois, Indiana, Michigan, Minnesota, North Carolina, New York, Tennessee, Texas, and Washington. Most people in this outbreak reported living in long-term care facilities or were hospitalized prior to becoming sick.

Not everyone reports when they’ve been affected by Listeria (and not everyone gets tested for it). Accordingly, it’s possible there are more sick people than were originally counted.

Continue reading →

Published on: March 25, 2025

Ozempic and Wegovy Linked to Vision Loss

By Moll Law Group

medical-5835701_640-e1741657233713 Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to manage type 2 diabetes and obesity and have the potential to help other medical problems like depression, addiction, and Alzheimer’s. Unfortunately, it also appears that one of the drugs’ potential side effects is a rare kind of vision loss, non-arteritic anterior ischemic optic neuropathy (NAION). Around 12% of people around the country has taken semaglutide drugs and around 6% of Americans are currently taking them. No direct causal link has been established, but as popularity of these drugs grow, it’s important to be aware of this possible risk. If you suffered NAION while on Ozempic, Wegovy or another GLP-1 drug, you should call the seasoned Chicago-based dangerous pharmaceuticals lawyers of Moll Law Group.

Call Moll Law Group About Your Semaglutide Claim

Only a small group of patients taking semaglutide have experienced vision issues. A JAMA study, one of several studies, looked at 9 patients that had vision trouble while taking semaglutide.

NAION is a non-inflammatory disease in which the blood supply to the optic nerve is harmed and the patient suffers a sudden partial vision loss that’s permanent. The study was initiated because a patient experienced a painless vision loss while on the drug but had the issue resolve favorably when semaglutide was stopped; when he went back on, he had the same problem with the other eye. The researcher looked into whether other neuro-ophthalmologists had seen this in their patients and found nine cases that are featured in his study. Seven out of nine of the patients, all of them in their 50s and 60s, had typical presentations of NAION, which usually affects only one eye at once, but some had unusual symptoms. Researchers are trying to figure out whether being on semaglutide actually causes NAION and other vision loss.

Continue reading →

Published on: March 18, 2025

Class II Recall of Baked Goods Made by FGF Brands

By Moll Law Group

donuts-2969490_1280-e1739548302659 In February, the Food and Drug Administration (FDA) announced that it is recalling 60 baked products due to potential listeria contamination concerns. Around 2 million baked goods manufactured by FGF Brands, which is a pastry wholesaler, were affected. These baked goods, which were made before December 13, 2024, include French crullers, fritters, cinnamon sticks, filled and flavored doughnuts. If you suffered listeria as a result of a baked good made by FGF brands, you should contact Moll Law Group to determine your legal options. Billions have been recovered in product liability lawsuits with which we’ve been involved.

Call Moll Law Group About Your Baked Goods Claim

The recall was first issued in January but was upgraded to a Class II recall; these are recalls where use of the recalled product could cause temporary adverse medical consequences or where the probability of serious negative consequences is remote. Next steps for consumers were not automatically provided by the FDA.

If you suffered listeria poisoning or listeriosis, you may have a basis to sue for damages. Listeriosis is a foodborne bacterial infection that’s commonly caused by the bacterium listeria monocytogenes. As the third leading cause of death from foodborne sickness, listeria affects around 1600 Americans each year, according to the Centers for Disease Control and Prevention (CDC) and can be especially serious when suffered by older adults, those with weakened immune systems, and pregnant women. It’s estimated that about 260 people die each year from infections and symptoms include muscle aches, headache, fever, stiff neck, loss of balance, convulsions, diarrhea, and confusion. Those who are pregnant may suffer miscarriage, stillbirth, premature delivery, or their newborns may suffer life-threatening infections. In the worst case, listeria can result in death.

Continue reading →

Published on: March 11, 2025

FDA Bans Red No. 3, the Artificial Coloring in Many Products

By Moll Law Group

red-3270956_640-e1739031721374 Red No. 3 is used as bright red artificial coloring in candy, cereal, fruit cocktails, strawberry-flavored milkshakes, and other foods and beverages. It’s ubiquitous. And so it’s alarming that data has surfaced that the dye can cause cancer in lab animals; specifically, evidence reveals that lab male rats exposed to heightened Red No. 3 levels developed cancer.

The FDA recently banned use of Red No. 3, but the Center for Science in the Public Interest has commented that it exists in thousands of—a whopping 9200—products. Notably, the FDA isn’t banning Red No. 40, another artificial dye linked to problems, specifically behavioral ones, in kids.

Food manufacturers can take until Jan. 15, 2027, to reformulate their products, which means consumers should be alert to ingredient lists and avoid products with Red No. 3. Those manufacturers of ingested drugs that include Red No. 3 such as supplements have until January 15, 2028.

Continue reading →

Published on: March 4, 2025

The FDA Makes Announcements Related to Smoking and Nicotine Addiction

By Moll Law Group

cigarette-7285317_640 2025 opened with announcements from the U.S. Food and Drug Administration (FDA) about cessation of smoking and the reduction of nicotine addiction. The first of the two announcements was a Notice of Proposed Rulemaking. This would call for a reduction in nicotine in combustible tobacco products to levels that are not addictive. This has been requested by public health advocates since 2009’s Family Smoking Prevention and Tobacco Control Act, which authorized such a change. The agency has set out a comment period that from January 16 all the way to September 15 of this year. However, the other announcement had to do with authorizing 3 mg and 6 mg nicotine content in a broader range of flavors of 20 Zyn nicotine pouches, which seems potentially dangerous for children. If your child was harmed by a nicotine pouch or other addictive nicotine product, call the knowledgeable product liability lawyers of Moll Law Group.

Consult the Trustworthy Moll Law Group About Your Nicotine Claim

In a time when the harms of nicotine to the body and brain, particularly on youth brain development, are increasingly clear, it seems surprising that the FDA would authorize 20 Zyn nicotine pouches in multiple attention-grabbing flavors like Peppermint, Chill, Smooth, Citrus, and Cinnamon. The second announcement seems to cut against the general tendency of the FDA to try to spur smoking cessation, such as by calling for reductions of nicotine in other products.

The agency justifies the decision allowing for greater marketing efforts with the claim that adults who use Zyn have switched entirely to those products to consume nicotine rather than smoke cigarettes or obtain smokeless tobacco. It claims that the Zyn products have less deleterious chemicals than those other products. It also argues that it will keep an eye on Zyn marketing to make sure the manufacturer is complying with the nuances of the marketing order—Zyn isn’t allowed to promote these products to children or teens, and the marketing order can be rescinded for noncompliance.

Continue reading →

Published on: February 25, 2025

Depo-Provera Claims Now Centralized and Part of Multidistrict Litigation

By Moll Law Group

injection-957260_640-e1739547652876 In an important legal step, the Depo-Provera birth control lawsuits have been centralized and transferred to multidistrict litigation that will take place in Florida. There were 27 lawsuits pending in 8 districts, and another 41 related actions pending in 15 districts. Plaintiffs had proposed to centralize the litigation in the Northern District of California or the Central District of California. However, the Panel on Multidistrict Litigation elected to move the cases to Florida. If you were harmed by Depo-Provera, you may have grounds to pursue damages in a product liability lawsuit. The seasoned Chicago-based lawyers of Moll Law Group represent plaintiffs around the country. Billions have been recovered in product liability lawsuits with which we’ve been involved.

Call Moll Law Group About the Harm You’ve Suffered from Depo-Provera

The plaintiffs who brought Depo-Provera lawsuits have alleged that they used the injectable contraceptive. Studies now show that long-term use of Depo-Provera can result in an increased risk of developing meningiomas (types of brain tumor) and the plaintiffs argued that they developed intracranial meningioma that was caused by use of Depo-Provera or a generic version of it. They sought centralization of these claims because they have substantially similar misrepresentation and product liability claims.

The Judicial Panel on Multidistrict Litigation found that the actions that were brought before them involve common questions of fact and that centralizing these cases in the Northern District of Florida will serve the parties’ convenience, as well as the witnesses, and promote the just and efficient conduct of the litigation.

Continue reading →

Published on: February 18, 2025

USDA Report finds Boar’s Head listeria outbreak was due to poor sanitation practices

By Moll Law Group

charcuterie-338498_6401-e1739031396223 Last July, Boar’s Head recalled liverwurst products due to a listeria outbreak. This recall eventually expanded and came to encompass sliced hams and sausages produced at the same plant as the liverwurst. Recently, the United States Department of Agriculture determined that a Boar’s Head facility’s inadequate sanitation practices contributed to the serious listeria outbreak last year. This was an outbreak from July through November that killed 10 people and resulted in hospitalizations of even more. The report from the USDA shows disturbing yet routine sanitation violations.

Call Moll Law Group About Your Claim

The USDA’s report examines alarming facility conditions that included dead bugs, mildew and black mold near machines, condensation dripping onto exposed products, broken flooring that could retain moisture that would make conditions for the meat wet, and meat and fat residue from the prior day’s production on packaging and other equipment.

Boar’s Head has expressed that it is cooperating with the USDA investigation and is trying to improve food safety programs, such as by implementing greater food safety control procedures and more serious testing at the poultry and meat facilities.

Continue reading →